Skip to main content
. 2022 Mar 1;13:754401. doi: 10.3389/fendo.2022.754401

Figure 1.

Figure 1

Analysis of microbiota dispersion (%) among patients with T1DM. The data present microbiota changes at the phylum (A), genus (B), and species levels (C). The amount of microbiota was normalized with that observed before intervention. Statistical difference between the probiotic group and placebo is indicated by a white two-way arrow. Placebo group: T1DM patients receive regular insulin treatment but no additional probiotic supplementation. Probiotic group: T1DM patients receive regular insulin treatment with additional probiotic supplementation.